IRETA was pleased to participate in the National Behavioral Health Quality and Best Practices Pledge event at the U.S. Department of Health and Human Services in Washington, D.C., on July 29th. HHS convened healthcare leaders, medical societies, providers, and behavioral health experts who pledged to strengthen the nation’s behavioral health system by advancing best practices to improve patient care and outcomes […]
IRETA to Deliver a Workshop at the National Opioid Settlement Conference in Denver
IRETA will participate in the National Opioid Settlement Conference, taking place June 17–19 in Denver, Colorado. The conference will bring together leaders, practitioners, advocates, and community partners working to support effective, transparent, and evidence-informed use of opioid settlement funds. IRETA is looking forward to connecting with others who are helping communities make thoughtful decisions about settlement investments and overdose […]
Avoiding Industry Influence in Opioid Settlement Spending: Key Principles for Decision-Makers
IRETA’s work on neuromodulation devices was recently featured as part of a poster presentation at the Rx Summit in Nashville, TN. The poster, Avoiding Industry Influence in Opioid Settlement Spending, outlines key principles to help guide how opioid settlement funds are allocated—emphasizing that investments should be grounded in comparative effectiveness, cost-efficiency, equity, and demonstrated impact on overdose outcomes. […]
Making Opioid Settlement Funds Count: Dr. Hulsey Presents the OSPRI Tool at Bloomberg Overdose Prevention Initiative Partners Meeting
Last month, Bloomberg Philanthropies held its 2026 Bloomberg Overdose Prevention Initiative Partners Meeting in New York City. Dr. Hulsey delivered a workshop with colleagues from the CDC Foundation entitled, “Evaluating impact – Using web-based tools to assess state and local overdose prevention programs and investments”. Overdose prevention planning efforts, especially with opioid settlement funds, often struggle with […]
